Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

TERN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $2,631,777.03

Terns Pharmaceuticals Insider Trading History Chart

Terns Pharmaceuticals Share Price & Price History

^$9.01

▲ +0.22 (2.50%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Nvidia insiders dumping shares

From Porter & Company | Ad

All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.

To see Porter Stansberry's new AI prediction go here now.

Terns Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/15/2024	Carl L Gordon	Director	Sell	50,976	$10.00	$509,760.00	756,258
4/3/2024	Vivo Opportunity, Llc	Major Shareholder	Sell	138,066	$6.20	$856,009.20	268,573
4/1/2024	Vivo Opportunity, Llc	Major Shareholder	Sell	181,117	$6.99	$1,266,007.83	275,772
12/23/2022	Orbimed Advisors Llc	Director	Buy	137,931	$7.25	$999,999.75	4,882,854
12/23/2022	Vivo Opportunity, Llc	Major Shareholder	Buy	758,620	$7.25	$5,499,995.00	4,340,212
11/23/2022	Biosciences Fund V L.P. Lav	Major Shareholder	Sell	1,500,000	$5.50	$8,250,000.00	405,583
9/7/2022	Vivo Opportunity, Llc	Major Shareholder	Buy	600,000	$3.60	$2,160,000.00	3,581,592
8/16/2022	Hongbo Lu	Director	Buy	1,500,000	$2.42	$3,630,000.00	2,981,592
8/15/2022	Vivo Opportunity, Llc	Major Shareholder	Buy	1,218	$2.99	$3,641.82	1,481,592
8/12/2022	Vivo Opportunity, Llc	Major Shareholder	Buy	1,123,021	$2.98	$3,346,602.58	1,480,374

Obama wins Presidential debate

From Porter & Company | Ad

When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.”

Please, watch this now before it’s too late.

SEC Filings (Institutional Ownership Changes) for Terns Pharmaceuticals (NASDAQ:TERN)

98.26% of Terns Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Terns Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/26/2024	Bank of New York Mellon Corp	176,673	$1.20M	0.0%	+56.8%	0.273%
7/11/2024	Salem Investment Counselors Inc.	371,600	$2.53M	0.1%	N/A	0.575%
7/10/2024	Simplicity Wealth LLC	10,561	$72K	0.0%	N/A	0.016%
5/20/2024	Virtu Financial LLC	44,307	$0.29M	0.0%	N/A	0.069%
5/17/2024	Walleye Trading LLC	15,000	$98K	0.0%	N/A	0.023%
5/17/2024	Ikarian Capital LLC	88,497	$0.58M	0.1%	-46.5%	0.137%
5/16/2024	California State Teachers Retirement System	32,110	$0.21M	0.0%	-13.2%	0.050%
5/16/2024	Janus Henderson Group PLC	2,003,263	$13.13M	0.0%	+40.6%	3.097%
5/16/2024	Kennedy Capital Management LLC	15,466	$0.10M	0.0%	N/A	0.024%
5/15/2024	Price T Rowe Associates Inc. MD	20,694	$0.14M	0.0%	+12.3%	0.032%
5/15/2024	Affinity Asset Advisors LLC	450,000	$2.95M	0.4%	+581.8%	0.696%
5/14/2024	EntryPoint Capital LLC	13,370	$88K	0.1%	-52.7%	0.021%
5/10/2024	Vanguard Group Inc.	2,199,006	$14.43M	0.0%	+0.5%	3.400%
5/8/2024	Russell Investments Group Ltd.	632,965	$4.15M	0.0%	+127.9%	0.979%
5/7/2024	Swiss National Bank	61,000	$0.40M	0.0%	-10.2%	0.094%
4/29/2024	China Universal Asset Management Co. Ltd.	11,889	$78K	0.0%	+66.3%	0.018%
2/15/2024	Great Point Partners LLC	1,309,975	$8.50M	1.5%	+102.8%	2.120%
2/14/2024	Braidwell LP	2,318,050	$15.04M	0.6%	-18.4%	3.751%
2/14/2024	Pale Fire Capital SE	49,014	$0.32M	0.0%	+222.4%	0.079%
2/13/2024	Affinity Asset Advisors LLC	66,000	$0.43M	0.1%	-79.7%	0.107%
2/12/2024	Decheng Capital LLC	714,285	$4.64M	1.3%	N/A	1.156%
2/9/2024	Franklin Resources Inc.	2,307,834	$14.98M	0.0%	+7.4%	3.735%
2/9/2024	Dynamic Technology Lab Private Ltd	16,322	$0.11M	0.0%	N/A	0.026%
2/6/2024	AJOVista LLC	8,943	$58K	0.1%	N/A	0.014%
2/5/2024	Russell Investments Group Ltd.	277,741	$1.80M	0.0%	N/A	0.449%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	9,350	$61K	0.0%	-16.4%	0.015%
1/29/2024	Simplicity Solutions LLC	10,452	$68K	0.0%	N/A	0.017%
1/25/2024	Bleakley Financial Group LLC	10,452	$68K	0.0%	N/A	0.017%
1/24/2024	China Universal Asset Management Co. Ltd.	7,147	$46K	0.0%	+358.1%	0.012%
11/22/2023	Graham Capital Management L.P.	82,978	$0.42M	0.0%	+186.3%	0.134%
11/15/2023	Acuta Capital Partners LLC	555,260	$2.79M	1.9%	-42.8%	0.909%
11/15/2023	Adage Capital Partners GP L.L.C.	100,000	$0.50M	0.0%	-33.3%	0.164%
11/15/2023	Affinity Asset Advisors LLC	325,000	$1.64M	0.5%	N/A	0.532%
11/14/2023	Braidwell LP	2,840,052	$14.29M	0.4%	+54.2%	4.650%
11/14/2023	PEAK6 Investments LLC	19,097	$96K	0.0%	+35.5%	0.031%
11/14/2023	Pale Fire Capital SE	15,202	$76K	0.0%	N/A	0.025%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	67,957	$0.34M	0.0%	-5.9%	0.111%
11/13/2023	Silverarc Capital Management LLC	500,000	$2.52M	0.8%	-16.6%	0.819%
11/13/2023	FMR LLC	5,118,050	$25.74M	0.0%	-27.4%	8.381%
11/7/2023	Barclays PLC	54,327	$0.27M	0.0%	-79.3%	0.089%
9/21/2023	Barclays PLC	262,918	$2.30M	0.0%	-50.8%	0.431%
9/8/2023	Tucker Asset Management LLC	2,824	$25K	0.0%	N/A	0.005%
8/15/2023	Silverarc Capital Management LLC	599,668	$5.25M	1.6%	-10.2%	0.982%
8/15/2023	Suvretta Capital Management LLC	5,561,835	$48.67M	2.6%	+61.3%	9.107%
8/15/2023	HighVista Strategies LLC	179,670	$1.57M	0.7%	+22.3%	0.294%
8/15/2023	Braidwell LP	1,842,352	$16.12M	0.5%	-7.7%	3.017%
8/14/2023	Deep Track Capital LP	1,099,192	$9.62M	0.4%	N/A	1.800%
8/14/2023	Driehaus Capital Management LLC	1,621,779	$14.19M	0.2%	-34.3%	2.656%
8/14/2023	Graham Capital Management L.P.	28,980	$0.25M	0.0%	N/A	0.047%
8/11/2023	VR Adviser LLC	2,972,869	$26.01M	4.2%	-17.9%	4.868%
8/11/2023	Franklin Resources Inc.	1,484,654	$12.99M	0.0%	+1.9%	2.431%
8/11/2023	Trexquant Investment LP	53,901	$0.47M	0.0%	N/A	0.088%
8/4/2023	American International Group Inc.	20,627	$0.18M	0.0%	N/A	0.036%
8/3/2023	Barclays PLC	262,918	$2.30M	0.0%	-50.8%	0.464%
7/27/2023	Victory Capital Management Inc.	73,930	$0.65M	0.0%	N/A	0.130%
5/15/2023	Atom Investors LP	51,951	$0.62M	0.3%	N/A	0.092%
5/12/2023	Crosspoint Financial LLC	12,054	$0.14M	1.5%	-19.9%	0.021%
5/12/2023	Mirabella Financial Services LLP	33,334	$0.40M	0.1%	N/A	0.059%
5/11/2023	FMR LLC	7,642,758	$90.49M	0.0%	+3.6%	13.486%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	11,963	$0.14M	0.0%	N/A	0.021%
5/9/2023	Integral Health Asset Management LLC	100,000	$1.18M	0.2%	N/A	0.176%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	2,482	$29K	0.0%	-50.9%	0.004%
5/4/2023	Barclays PLC	534,760	$6.33M	0.0%	+3.5%	0.944%
5/3/2023	Jump Financial LLC	18,356	$0.22M	0.0%	N/A	0.032%
2/15/2023	Endurant Capital Management LP	135,994	$1.38M	0.6%	N/A	0.362%
2/15/2023	Fairmount Funds Management LLC	2,040,000	$20.77M	3.3%	-0.5%	5.424%
2/14/2023	683 Capital Management LLC	28,000	$0.29M	0.0%	N/A	0.074%
2/14/2023	Pura Vida Investments LLC	605,079	$6.16M	0.3%	-17.0%	1.609%
2/14/2023	Driehaus Capital Management LLC	2,294,376	$23.36M	0.3%	+43.6%	6.100%
2/13/2023	Vivo Capital LLC	6,657,992	$67.78M	7.8%	+12.9%	17.703%
2/10/2023	Franklin Resources Inc.	750,024	$7.64M	0.0%	N/A	1.994%
2/10/2023	HRT Financial LP	35,090	$0.36M	0.0%	N/A	0.093%
2/9/2023	Monashee Investment Management LLC	122,500	$1.25M	0.5%	N/A	0.326%
2/9/2023	Citigroup Inc.	46,048	$0.47M	0.0%	+6,468.9%	0.122%
2/8/2023	Crosspoint Financial LLC	15,054	$0.15M	1.7%	N/A	0.040%
2/1/2023	Bank of Montreal Can	194,100	$1.98M	0.0%	N/A	0.516%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	5,050	$51K	0.0%	N/A	0.013%
11/15/2022	Pura Vida Investments LLC	728,600	$4.29M	0.2%	N/A	2.873%
11/15/2022	Caas Capital Management LP	85,851	$0.21M	0.0%	-12.0%	0.339%
11/15/2022	Commodore Capital LP	205,870	$1.21M	0.2%	N/A	0.812%
11/14/2022	Armistice Capital LLC	600,000	$3.53M	0.1%	+85.7%	2.366%
11/14/2022	Vivo Capital LLC	5,899,372	$34.75M	3.8%	+120.5%	23.259%
11/14/2022	Boothbay Fund Management LLC	135,719	$0.80M	0.0%	+27.2%	0.535%
11/14/2022	VR Adviser LLC	3,707,891	$21.84M	3.2%	N/A	14.619%
11/9/2022	Fairmount Funds Management LLC	2,050,000	$12.08M	2.1%	N/A	8.084%
11/3/2022	Barclays PLC	659,098	$3.88M	0.0%	+4,921.7%	2.599%
10/28/2022	Silverarc Capital Management LLC	14,473	$85K	0.0%	N/A	0.057%
10/25/2022	Raymond James Financial Services Advisors Inc.	20,830	$0.12M	0.0%	N/A	0.082%
8/16/2022	Driehaus Capital Management LLC	210,074	$0.52M	0.0%	+498.5%	0.828%
8/12/2022	Ikarian Capital LLC	700,000	$1.74M	0.3%	N/A	2.769%
8/12/2022	Affinity Asset Advisors LLC	401,268	$1M	0.4%	N/A	1.587%
7/27/2022	Bailard Inc.	20,300	$50K	0.0%	N/A	0.080%
7/15/2022	Marquette Asset Management LLC	57,876	$0.14M	0.0%	+165.5%	0.229%
5/10/2022	Decheng Capital Management III Cayman LLC	714,285	$2.12M	0.7%	N/A	2.827%
4/26/2022	Marquette Asset Management LLC	21,802	$65K	0.0%	+31.2%	0.086%
2/14/2022	Suvretta Capital Management LLC	1,238,800	$8.76M	0.2%	+10.0%	4.903%
2/8/2022	Northern Trust Corp	112,036	$0.79M	0.0%	-4.2%	0.443%
1/19/2022	Marquette Asset Management LLC	16,619	$0.12M	0.0%	N/A	0.066%
11/15/2021	Caas Capital Management LP	85,851	$0.90M	0.0%	+319.9%	0.342%
11/12/2021	Geode Capital Management LLC	193,336	$2.01M	0.0%	+35.1%	0.769%

Data available starting January 2016

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

Today's Range

Now: $9.01

$8.86

$9.22

50 Day Range

MA: $7.40

$5.86

$9.99

52 Week Range

Now: $9.01

$3.26

$10.03

Volume

572,361 shs

Average Volume

999,000 shs

Market Capitalization

$582.74 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Terns Pharmaceuticals?: Terns Pharmaceuticals' top insider shareholders include:
Orbimed Advisors Llc (Director)
Vivo Opportunity, Llc (Major Shareholder)
Hongbo Lu (Director)
Carl L Gordon (Director)
Biosciences Fund V LP Lav (Major Shareholder)
Learn More about top insider investors at Terns Pharmaceuticals.
Who are the major institutional investors of Terns Pharmaceuticals?: Terns Pharmaceuticals' top institutional shareholders include:
Salem Investment Counselors Inc. — 0.57%
Bank of New York Mellon Corp — 0.27%
Simplicity Wealth LLC — 0.02%
Learn More about top institutional investors of Terns Pharmaceuticals stock.
Which institutional investors are buying Terns Pharmaceuticals stock?: Within the last quarter, TERN stock was purchased by institutional investors including:
Salem Investment Counselors Inc.
Bank of New York Mellon Corp
Simplicity Wealth LLC
During the previous year, these company insiders have bought Terns Pharmaceuticals stock:
Orbimed Advisors Llc (Director)
Vivo Opportunity, Llc (Major Shareholder)
Hongbo Lu (Director)
Learn More investors buying Terns Pharmaceuticals stock.

625,000% Gain

From Crypto Swap Profits | Ad

>> Dive into the Workshop Here